A nurse is caring for a client who has poison ivy dermatitis. Which of the following treatment options should the nurse suggest the client use within the first few days to alleviate pruritus?

The scenario focuses on Type IV hypersensitivity reactions caused by urushiol oil in poison ivy. Knowledge of inflammatory pathways and topical pharmacology is necessary to determine the most effective intervention for suppressing the T-cell mediated immune response and associated itching. Choice A rationale Oral antihistamines target H1 receptors to reduce itching but do not address the underlying cell-mediated inflammatory response of contact dermatitis. While they may provide sedation to help the client sleep, they are not the primary treatment for urushiol-induced inflammation. Choice B rationale Antifungal creams treat dermatophyte infections or yeast overgrowth on the skin. Poison ivy is an allergic contact dermatitis reaction to a plant resin, not a fungal infection, making antifungal therapy ineffective and inappropriate for this inflammatory condition. Choice C rationale Systemic antibiotics are used to treat bacterial infections like cellulitis or impetigo. Unless the client develops a secondary bacterial infection from scratching the lesions, antibiotics serve no purpose in treating the allergic reaction caused by the poison ivy. Choice D rationale Topical corticosteroids are the mainstay for allergic contact dermatitis because they inhibit cytokine production and decrease the inflammatory response. Applying these medications directly to the affected area effectively reduces skin edema, redness, and the intensity of pruritus.